Results for tag: "Farnesoid X Receptor Agonist"

The Farnesoid X Receptor Agonist (FXR) market is a subset of the larger Liver and Kidney Disorders Drugs market. FXR agonists are drugs that activate the FXR receptor, which is a nuclear receptor found in the liver and kidneys. Activation of the FXR receptor can help to reduce the symptoms of liver and kidney disorders, such as cirrhosis, fatty liver disease, and chronic kidney disease. FXR agonists are typically administered orally, and can be used in combination with other drugs to treat these disorders. FXR agonists are a relatively new class of drugs, and the market is still in its early stages. However, the potential for FXR agonists to improve the treatment of liver and kidney disorders has led to increased interest in the market. Some companies in the FXR agonist market include Intercept Pharmaceuticals, Galmed Pharmaceuticals, and Allergan. Show Less Read more